rs2298432
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002745.5(MAPK1):c.*9+295T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.693 in 205,208 control chromosomes in the GnomAD database, including 51,389 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.72 ( 40493 hom., cov: 32)
Exomes 𝑓: 0.63 ( 10896 hom. )
Consequence
MAPK1
NM_002745.5 intron
NM_002745.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.25
Publications
36 publications found
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
- Noonan syndrome 13Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.922 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MAPK1 | ENST00000215832.11 | c.*9+295T>G | intron_variant | Intron 8 of 8 | 1 | NM_002745.5 | ENSP00000215832.7 | |||
| MAPK1 | ENST00000491588.1 | n.234+295T>G | intron_variant | Intron 1 of 1 | 2 | |||||
| MAPK1 | ENST00000398822.7 | c.*304T>G | downstream_gene_variant | 1 | ENSP00000381803.3 |
Frequencies
GnomAD3 genomes AF: 0.715 AC: 108700AN: 152020Hom.: 40430 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
108700
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.631 AC: 33472AN: 53070Hom.: 10896 AF XY: 0.630 AC XY: 17243AN XY: 27386 show subpopulations
GnomAD4 exome
AF:
AC:
33472
AN:
53070
Hom.:
AF XY:
AC XY:
17243
AN XY:
27386
show subpopulations
African (AFR)
AF:
AC:
1659
AN:
1796
American (AMR)
AF:
AC:
1407
AN:
1860
Ashkenazi Jewish (ASJ)
AF:
AC:
1508
AN:
2218
East Asian (EAS)
AF:
AC:
1752
AN:
3840
South Asian (SAS)
AF:
AC:
1502
AN:
2448
European-Finnish (FIN)
AF:
AC:
1003
AN:
1680
Middle Eastern (MID)
AF:
AC:
198
AN:
270
European-Non Finnish (NFE)
AF:
AC:
22109
AN:
35404
Other (OTH)
AF:
AC:
2334
AN:
3554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
600
1200
1801
2401
3001
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.715 AC: 108824AN: 152138Hom.: 40493 Cov.: 32 AF XY: 0.712 AC XY: 52983AN XY: 74368 show subpopulations
GnomAD4 genome
AF:
AC:
108824
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
52983
AN XY:
74368
show subpopulations
African (AFR)
AF:
AC:
38648
AN:
41550
American (AMR)
AF:
AC:
11532
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2357
AN:
3470
East Asian (EAS)
AF:
AC:
2545
AN:
5174
South Asian (SAS)
AF:
AC:
2978
AN:
4820
European-Finnish (FIN)
AF:
AC:
6103
AN:
10552
Middle Eastern (MID)
AF:
AC:
216
AN:
294
European-Non Finnish (NFE)
AF:
AC:
42362
AN:
67968
Other (OTH)
AF:
AC:
1529
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1463
2927
4390
5854
7317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.